Integra LifeSciences Schedules Conference Call for Thursday, November 2 to Discuss Third Quarter 2006 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J.--(BUSINESS WIRE)--Sept. 12, 2006--Integra LifeSciences Holdings Corporation (NASDAQ:IART) has scheduled a conference call for 9:00 AM EST on Thursday, November 2 to discuss financial results for the third quarter September 30, 2006 and to update forward-looking financial guidance. Financial results for the third quarter 2006 will be announced via a news release issued before the market opens on November 2.
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward-looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 913-981-5560 or through a webcast via a link provided on Integra's website at www.Integra-LS.com. Access to a replay is available through November 16, 2006 by dialing 719-457-0820 (PIN 5413428) or through the webcast.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for Integra's products are neurosurgery, reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world.
CONTACT:
Integra LifeSciences Holdings Corporation
Maureen Bellantoni
Executive Vice President and Chief Financial Officer
609-936-6822
Maureen.bellantoni@integra-ls.com
or
John Bostjancic
Vice President Corporate Development Investor Relations
609-936-2239
jbostjancic@integra-ls.com
SOURCE: Integra LifeSciences Holdings Corporation